Letter to the editor: risk comorbidities of COVID-19 in Parkinson's disease patients in Germany
Neurol Res Pract
.
2020;2(1):22.
doi: 10.1186/s42466-020-00069-x.
Epub 2020 Aug 11.
Authors
Daniel Richter
1
,
Dirk Bartig
2
,
Christos Krogias
1
,
Lars Tönges
1
3
Affiliations
1
Department of Neurology, St. Josef-Hospital, Ruhr University Bochum, Gudrunstr. 56, 44791 Bochum, Germany.
2
DRG Market, Osnabrück, Germany.
3
Neurodegeneration Research, Protein Research Unit Ruhr (PURE), Ruhr University Bochum, Bochum, Germany.
PMID:
32835166
PMCID:
PMC7417199
DOI:
10.1186/s42466-020-00069-x
No abstract available
Keywords:
COVID-19; Infection risk; Parkinson’s disease.